Skip to main
TWST
TWST logo

TWST Stock Forecast & Price Target

TWST Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 10%
Sell 10%
Strong Sell 0%

Bulls say

Twist Bioscience Corp has demonstrated a strong positive outlook through its improved financial guidance, raising its gross margin expectation for FY25 to 49.5% and projecting the exit of FY25 with margins exceeding 50%. Additionally, the company has reiterated its revenue guidance while also increasing expectations for adjusted EBITDA, indicating stronger operational performance ahead. The anticipated spin-off is expected to enhance visibility to adjusted EBITDA profitability, further reinforcing the company's financial stability and growth potential.

Bears say

Twist Bioscience Corp faces significant financial challenges, as its data business has consistently been a headwind, negatively impacting its adjusted EBITDA by approximately $5 million per quarter. This ongoing burden suggests persistent operational inefficiencies within that segment, which could hinder overall profitability. Furthermore, the reliance on a limited revenue source primarily from the United States may exacerbate vulnerabilities, contributing to a negative outlook for the company’s stock performance.

TWST has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 10% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Twist Bioscience Corp (TWST) Forecast

Analysts have given TWST a Buy based on their latest research and market trends.

According to 10 analysts, TWST has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Twist Bioscience Corp (TWST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.